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1. Introduction 
The.anticoagulant activity of heparin is due to its 
ability to specifically bind to antithrombin and thus 
strikingly accelerate the rate of inactivation of a 
number of the enzymes involved in the coagulation 
mechanism [ 1,2] . It was recently demonstrated that 
heparin may be separated into distinct fractions, 
having high and low affinity, respectively, for anti- 
thrombin [3,4] ; the high-affinity fraction showed 
exceedingly high antigoagulant activity, whereas the 
low-affinity fraction was almost inactive. A preliminary 
structural characterization of the two heparin frac- 
tions failed to reveal any obvious dissimilarities [4]. 
In the present study heparin fragments capable of 
binding to antithrombin were isolated after digestion 
of heparin-antithrombin complexes with a bacterial 
heparinase. Fragments with high affinity for anti- 
thrombin were derived from high-affinity heparin 
only. They had a molecular weight of about 4-5 X 103. 
These findings suggest hat binding of heparin to 
antithrombin may require a specific sequence of 
variously substituted sugar residues. 
2. Materials 
Radioactive heparin was prepared from mouse 
mastocytoma tissue, after labeling in vitro with [3H] 
galactose (the procedure given in ref. [S] was followed, 
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except that 2 mCi t3H] galactose was substituted for 
the [‘4C]glucose). The product was digested with 
chondroitinase ABC and was purified by ion-exchange 
chromatography on DEAE-cellulose [6] , yielding 
heparin with a specific activity of 1.5 X lo4 cpm/ng 
uranic acid. 
Purified bovine antithrombin (generously donated 
by Dr I. Bjork at this department) was coupled to 
Sepharose 4B as previously described [4]. 
Heparinase was isolated as previously described from 
Havobacterium heparinum [7]. 
3. Methods 
Methods for the determination of uranic acid, 
radioactivity and ratios of radioactive glucuronic 
acid/iduronic acid in heparin have been described 
[VI. 
Selective deamination of N-sulfated hexosamine 
residues was achieved by the method of Shively and 
Conrad [9]. 
Digestions with bacterial heparinase were carried 
out under conditions described previously [lo] . 
4. Results and discussion 
3H-Labeled heparin (17 X lo6 c.p.m.) was 
separated into low-, intermediate-, and high-affinity 
fractions by affinity chromatography on antithrombin- 
Sepharose (fig. 1; the two latter fractions would both 
be included in the high-affinity heparin described in 
ref. [4]). Corresponding fractions derived from 
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Fig.1. Fractionation of [ sH]heparin by affinity chromato- 
graphy on antithrombin-Sepharose (41. Gradient elution 
with sodium chloride (in 0.05 M Tris-HCl, pH 7.4) was 
started at the point indicated by the arrow. Effluent fractions 
of about 3 ml were collected, analyzed for radioactivity and 
pooled as indicated into low-affinity (LA), intermediate- 
affinity (IA) and high-affinity (HA), heparin respectively. The 
peak of break-through material was due to overloading, 
17 X lo6 cpm of [3H]heparin being applied to a 3 ml- 
column. After two successive reapplications of the break- 
through fraction all the label was recovered in the three frac- 
tions LA, IA, HA; the final yield of these fractions amounted 
to 37%, 27% and 36%, respectively, of the starting material. 
The fractions were desalted by dialysis and stored at -20”. 
(- - - -) NaCl concentration. 
commercially available heparin showed anticoagulant 
activities of 20, 240, and 290 B.P. units/mg, respectively. 
Samples of the three heparin fractions were mixed 
with antithrombin-Sepharose at low ionic strength; 
when all labeled polysaccharide had bound to the gel, 
heparinase was added and the samples were incubated 
as described in the legend to fig.2. Labeled oligo- 
saccharides were released from the heparin-anti- 
thrombin complexes. After about two hours of 
incubation the amounts of liberated material had 
reached a plateau value that could not be increased 
further by addition of fresh enzyme. This value was 
inversely related to the antithrombin affinity of the 
starting material, suggesting that the heparin molecules 
had been subjected to selective digestion, affecting 
primarily those portions not bound to the antithrombin. 
The heparinase-digested samples were transferred 
in toto to glass columns and the liberated 3H-labeled 
oligosaccharides were washed off the gels at low 
ionic strength (fig.3); the heparin fragments that had 
remained bound to the antithrombin-Sepharose gels 
were eluted with sodium chloride (linear gradient). 
The radioactivity recovered in the wash fractions 
corresponded to 39%, 78%, and 89%, of the original 
high-affinity, intermediate-affinity, and low-affinity 
heparin, respectively. 
Gradient elution produced peaks at low salt con- 
centration from all the three samples (fig.3; the 
products of intermediate-affinity heparin are not 
included). In addition, the intermediate- and high- 
affinity (fig.3B) heparins yielded more retarded com- 
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Fig.2. Digestion of heparin-antithrombin complex with hepa- 
rinase. Samples of (o) high-affinity (2 X lo6 c.p.m.); (0) 
intermediate-affinity (1.8.X lo6 c.p.m.); and (A) low-affinity 
(1.1 X lo6 c.p.m.) heparin were mixed with 1.5 ml of anti- 
thrombin-Sepharose in 0.1 M sodium acetate buffer pH 6.8 
(final volume, 3 ml) and were then incubated at 21°C until 
supernatants obtained by centrifugation at 1000 X g for 
5 min were essentially free of radioactivity. The samples were 
then mixed with 0.2 mg of heparinase and incubated at 29°C. 
Samples of 0.02 ml were withdrawn from the supernatant of 
the reaction mixture as indicated and analyzed for released 
radioactivity. More enzyme (0.1 mg) was added at the time 
indicated by the arrow. 
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Fig.3. Salt elution of products obtained by digestion of [‘HI 
heparin-antithrombin-Sepharose complex with heparinase. 
(A), Low-affinity heparin; (B), high-affinity heparin. The 
digests, prepared as described in the legend to fig.2, were 
poured into glass columns (0.6 X 4 cm) and the gels were 
washed with 0.1 M sodium acetate, pH 6.8. Elution with a 
linear gradient of NaCl (- - - -) in 0.1 M sodium acetate, 
pH 6.8, was started as indicated by the arrow. Fractions were 
pooled as shown by the horizontal bars, concentrated and 
desalted by passage through columns of Sephadex G-15. 
ponents, having approximately the same elution 
positions as the corresponding intact polysaccharides. 
Such retarded components were absent from the low- 
affinity heparin digest (fig.3A). On reapplication to 
the column the high-affinity fraction, HA-III, was 
quantitatively retained by the gel and required the 
same high salt concentration for elution as in the 
initial preparative experiment. 
Heparin fractions eluted from the antithrombin- 
Sepharose after heparinase digestion were subjected 
to gel chromatography on Sephadex G-l 00. Contrary 
to the undegraded parent polysaccharides the diges- 
tion products were quantitatively retarded on the 
column (fig.4). Fractions HA-II and HA-III both 
yielded distinct peaks of highly retarded material 
(peak elution volumes, 62 ml and 52 ml, respectively). 
As similarly retarded fragments were obtained from 
the intermediate-affinity heparin but not from the 
low-affinity heparin (fig.4) these components would 
seem to include the antithrombin-binding site(s) of 
heparin. In addition, all fractions having affinity for 
antithrombin contained a portion of less retarded 
molecules, emerging closely after the excluded volume 
of the column (peak elution volume, 30 ml). Analysis 
(by paper chromatography after acid hydrolysis and 
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Fig.4. Gel chromatography on Sephadex G-100 of fractions 
HA-II (0) and HA-III (0) derived from high-affinity heparin, 
and fraction LA-II (A) from low-affinity heparin (see fig.3). 
A sample of the intact parent polysaccharide (a) is included 
for comparison. The samples were applied to a 1.2 X 95 cm 
gel column, which was then eluted with 1.0 M NaCI in Tris- 
HCl, pH 7.4 at a rate of about 2 ml/h. Fractions of 1.0 ml 
were analyzed for radioactivity and pooled as indicated; the 
pools were concentrated and desalted by passage through 
Sephadex G-15. The two arrows indicate the peak elution 
positions of heparin fragments obtained by partial deamina- 
tion with nitrous acid. The molecular weight of the larger 
fragment was determined by sedimentation equilibrium ultra- 
centrifugation; the smaller fragment was a hexasaccharide, 
mol. wt. about 2000. Fragments of high-affinity heparin, less 
retarded than fraction HA-III on affinity chromatography 
(between 70 and 100 ml effluent volume; see fig.3B) behaved 
like fraction HA-III on Sephadex G-100. Furthermore, 
corresponding fragments of intermediate-affinity and 
high-affinity heparin appeared alike on gel chromatography. 
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ion-exchange treatment) of these larger-sized molecules 
showed the occurrence of labeled galactose and xylose; 
these components may thus represent polysaccharide- 
protein linkage regions joined by a core structure [ 111. 
Judging from the elution positions of appropriate 
markers (fig.4) the more retarded components of 
fractions HA-III and HA-II would have average mole- 
cular weights in the order of 4-5 X lo3 and 2-3 X 103, 
corresponding to approximately 12- 16 and 6- 10 
monosaccharide units, respectively. The molecular size 
of these fragments, remaining bound to the anti- 
thrombin after heparinase digestion, thus considerably 
exceeds that of the liberated digestion products. Gel 
chromatography of such products (fraction HA-I in 
fig.3) on Sephadex G-25 showed that more than 
80% of the material was retarded, disaccharides being 
the major product. In contrast, fraction HA-III 
was completely excluded from Sephadex G-25. 
This resistance of portions of the heparin molecule 
towards heparinase must be at least partly due to a 
protective effect of the antithrombin present during 
digestion, as no significant amounts of HA-III 
material could be detected after heparinase digestion 
of high-affinity heparin in the absence of anti- 
thrombin-Sepharose. 
The low-molecular weight components of fractions 
HA-II and HA-III did not contain any detectable 
amounts of labeled neutral sugar. Analysis with regard 
to uranic acid composition showed [3H]iduronic/ 
total [3H]uronic acid ratios of 5 1% and 5570, respec- 
tively; the ratio for the high-affinity heparin starting 
material was 54%. Treatment of the same components 
with nitrous acid resulted in degradation to di- and 
tetra-saccharides, as shown by gel chromatography on 
Sephadex G-25; hence, a major portion of the hexos- 
amine residues must have been N-sulfated [9] . The 
gross composition of the isolated fragments thus con- 
forms to that of ‘heparin’. A detailed investigation of 
these products will hopefully reveal the structure of 
the antithrombin-binding site in the heparin molecule. 
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